Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP553387.RA9LRqqeouMD-32V6URJpj5Si652nsJx_uYw99DybW0cY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP553387.RA9LRqqeouMD-32V6URJpj5Si652nsJx_uYw99DybW0cY130_assertion type Assertion NP553387.RA9LRqqeouMD-32V6URJpj5Si652nsJx_uYw99DybW0cY130_head.
- NP553387.RA9LRqqeouMD-32V6URJpj5Si652nsJx_uYw99DybW0cY130_assertion wasGeneratedBy ECO_0000203 NP553387.RA9LRqqeouMD-32V6URJpj5Si652nsJx_uYw99DybW0cY130_provenance.
- NP553387.RA9LRqqeouMD-32V6URJpj5Si652nsJx_uYw99DybW0cY130_assertion wasDerivedFrom befree-20150227 NP553387.RA9LRqqeouMD-32V6URJpj5Si652nsJx_uYw99DybW0cY130_provenance.
- NP553387.RA9LRqqeouMD-32V6URJpj5Si652nsJx_uYw99DybW0cY130_assertion SIO_000772 23435440 NP553387.RA9LRqqeouMD-32V6URJpj5Si652nsJx_uYw99DybW0cY130_provenance.
- NP553387.RA9LRqqeouMD-32V6URJpj5Si652nsJx_uYw99DybW0cY130_assertion evidence source_evidence_literature NP553387.RA9LRqqeouMD-32V6URJpj5Si652nsJx_uYw99DybW0cY130_provenance.
- NP553387.RA9LRqqeouMD-32V6URJpj5Si652nsJx_uYw99DybW0cY130_assertion description "[Hyperparathyroidism is the most common feature of MEN1 (95% of patients), pancreatic islet tumors or pancreatic NET (neuroendocrine tumor) occur in 40-70% and pituitary tumors in 30-40% of MEN 1 patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP553387.RA9LRqqeouMD-32V6URJpj5Si652nsJx_uYw99DybW0cY130_provenance.